Kirk D. Jones

15.1k total citations · 4 hit papers
141 papers, 8.9k citations indexed

About

Kirk D. Jones is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Physiology. According to data from OpenAlex, Kirk D. Jones has authored 141 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Pulmonary and Respiratory Medicine, 27 papers in Surgery and 26 papers in Physiology. Recurrent topics in Kirk D. Jones's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (61 papers), Occupational and environmental lung diseases (17 papers) and Sarcoidosis and Beryllium Toxicity Research (15 papers). Kirk D. Jones is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (61 papers), Occupational and environmental lung diseases (17 papers) and Sarcoidosis and Beryllium Toxicity Research (15 papers). Kirk D. Jones collaborates with scholars based in United States, Canada and Italy. Kirk D. Jones's co-authors include Harold R. Collard, Paul J. Wolters, Brett M. Elicker, Talmadge E. King, Joyce Lee, Brett Ley, Christopher J. Ryerson, Eric Vittinghoff, Jay H. Ryu and Laura L. Koth and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Kirk D. Jones

136 papers receiving 8.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis

2012 851 citations Brett Ley, Eric Vittinghoff et al. profile →
COVID ‐19 and Older Adults: What We Know

2020 649 citations Kirk D. Jones et al. profile →
Pathogenesis of Idiopathic Pulmonary Fibrosis

2013 641 citations Paul J. Wolters, Harold R. Collard et al. profile →
Predicting Survival Across Chronic Interstitial Lung Disease

2013 346 citations Eric Vittinghoff, Brett Ley et al. CHEST Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kirk D. Jones United States	44	6.0k	2.0k	1.2k	1.0k	883	141	8.9k
Michael Kreuter Germany	46	5.8k 1.0×	2.0k 1.0×	1.4k 1.2×	776 0.8×	759 0.9×	347	8.5k
Kevin R. Flaherty United States	55	9.1k 1.5×	3.0k 1.5×	1.1k 0.9×	1.2k 1.2×	438 0.5×	196	10.9k
Charlie Strange United States	49	6.2k 1.0×	1.7k 0.9×	738 0.6×	865 0.9×	1.1k 1.3×	244	9.3k
Jan‐Willem J. Lammers Netherlands	51	4.6k 0.8×	1.8k 0.9×	2.7k 2.2×	804 0.8×	1.7k 1.9×	184	10.7k
Ryan Woods Canada	33	4.0k 0.7×	1.4k 0.7×	1.4k 1.1×	697 0.7×	2.9k 3.3×	116	8.9k
Carol Farver United States	42	2.4k 0.4×	1.0k 0.5×	1.2k 1.0×	695 0.7×	776 0.9×	179	5.9k
Christopher J. Ryerson Canada	46	7.2k 1.2×	2.5k 1.3×	393 0.3×	810 0.8×	235 0.3×	201	8.5k
Sunita Ghosh Canada	41	1.7k 0.3×	3.1k 1.6×	1.3k 1.0×	812 0.8×	2.3k 2.6×	436	8.8k
Flora Peyvandi Italy	65	2.2k 0.4×	625 0.3×	1.6k 1.3×	1.0k 1.0×	831 0.9×	652	18.3k
Mehdi Nouraie United States	51	2.2k 0.4×	941 0.5×	1.4k 1.1×	1.3k 1.3×	1.7k 1.9×	328	8.3k

Countries citing papers authored by Kirk D. Jones

Since Specialization

Citations

This map shows the geographic impact of Kirk D. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk D. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk D. Jones more than expected).

Fields of papers citing papers by Kirk D. Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirk D. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk D. Jones. The network helps show where Kirk D. Jones may publish in the future.

Co-authorship network of co-authors of Kirk D. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Kirk D. Jones. A scholar is included among the top collaborators of Kirk D. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirk D. Jones. Kirk D. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jones, Kirk D., et al.. (2023). Systemic capillary leak syndrome secondary to decompression sickness. BMJ Case Reports. 16(7). e253045–e253045. 1 indexed citations

Jones, Kirk D., et al.. (2022). Persistence of persistent pulmonary hypertension of the newborn: A case of de novo TBX4 variant. Pulmonary Circulation. 12(3). e12108–e12108. 5 indexed citations

Woodard, Gavitt A., Johannes R. Kratz, Matthew A. Gubens, et al.. (2021). MO01.13 Molecular Risk Stratification is Independent of EGFR Mutation Status in Identifying Early Stage Non-Squamous Non-Small Cell Lung Cancer Patients at Risk for Recurrence and Likely to Benefit from Adjuvant Chemotherapy. Journal of Thoracic Oncology. 16(1). S21–S21. 1 indexed citations

Matsumoto, Shotaro, Xiaohui Fang, Maret G. Traber, et al.. (2020). Dose-Dependent Pulmonary Toxicity of Aerosolized Vitamin E Acetate. American Journal of Respiratory Cell and Molecular Biology. 63(6). 748–757. 48 indexed citations

Naikawadi, Ram P., Gary Green, Kirk D. Jones, et al.. (2020). Airway Epithelial Telomere Dysfunction Drives Remodeling Similar to Chronic Lung Allograft Dysfunction. American Journal of Respiratory Cell and Molecular Biology. 63(4). 490–501. 15 indexed citations

Ley, Brett, Dara G. Torgerson, Justin M. Oldham, et al.. (2019). Rare Protein-Altering Telomere-related Gene Variants in Patients with Chronic Hypersensitivity Pneumonitis. American Journal of Respiratory and Critical Care Medicine. 200(9). 1154–1163. 76 indexed citations

Liu, Gabrielle Y., Iazsmin Bauer Ventura, Brett M. Elicker, et al.. (2019). Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis. CHEST Journal. 156(4). 715–723. 44 indexed citations

Rotow, Julia, Anatoly Urisman, Caroline E. McCoach, et al.. (2019). P1.14-58 A Phase II Study to Evaluate Neoadjuvant Osimertinib for Surgically Resectable, EGFR-Mutant Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(10). S578–S578. 6 indexed citations

Elicker, Brett M., Kimberly Kallianos, Kirk D. Jones, & Travis S. Henry. (2018). Smoking-Related Lung Disease. Seminars in Ultrasound CT and MRI. 40(3). 229–238. 10 indexed citations

10.

Morisset, Julie, Eric Vittinghoff, Bo Young Lee, et al.. (2016). Predicting Mortality in Patients with Rheumatoid Arthritis Related Interstitial Lung Disease: Expanding The GAP Model. IRIS UNIMORE (University of Modena and Reggio Emilia). 193.

11.

Woodard, Gavitt A., Kirk D. Jones, & David M. Jablons. (2016). Lung Cancer Staging and Prognosis. Cancer treatment and research. 170. 47–75. 257 indexed citations

12.

Greenland, John R., Kirk D. Jones, Jeffrey A. Golden, et al.. (2012). Association of Large-Airway Lymphocytic Bronchitis with Bronchiolitis Obliterans Syndrome. American Journal of Respiratory and Critical Care Medicine. 187(4). 417–423. 36 indexed citations

13.

Allen, Thaddeus D., Elena M. Rodríguez Rodríguez, Kirk D. Jones, & J. Michael Bishop. (2011). Activated Notch1 Induces Lung Adenomas in Mice and Cooperates with Myc in the Generation of Lung Adenocarcinoma. Cancer Research. 71(18). 6010–6018. 89 indexed citations

14.

Allen, Thaddeus D., Chang‐Qi Zhu, Kirk D. Jones, et al.. (2011). Interaction between MYC and MCL1 in the Genesis and Outcome of Non–Small-Cell Lung Cancer. Cancer Research. 71(6). 2212–2221. 38 indexed citations

15.

Lee, Joyce, Jay H. Ryu, Brett M. Elicker, et al.. (2011). Gastroesophageal Reflux Therapy Is Associated with Longer Survival in Patients with Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 184(12). 1390–1394. 279 indexed citations

16.

Patil, Mohini A., Susie A. Lee, Everardo Macias, et al.. (2008). Role of Cyclin D1 as a Mediator of c-Met– and β-Catenin–Induced Hepatocarcinogenesis. Cancer Research. 69(1). 253–261. 73 indexed citations

17.

Tward, Aaron D., Kirk D. Jones, Stephen R. Yant, et al.. (2007). Distinct pathways of genomic progression to benign and malignant tumors of the liver. Proceedings of the National Academy of Sciences. 104(37). 14771–14776. 164 indexed citations

18.

Kinder, Brent W., Harold R. Collard, Laura L. Koth, et al.. (2007). Idiopathic Nonspecific Interstitial Pneumonia. American Journal of Respiratory and Critical Care Medicine. 176(7). 691–697. 242 indexed citations

19.

Chan, Andrew, et al.. (2003). Lymphangioleiomyomatosis and SZ α1-Antitrypsin Disease*. CHEST Journal. 124(2). 763–765. 3 indexed citations

20.

Frank, James A., J. Antonio Gutierrez, Kirk D. Jones, et al.. (2002). Low Tidal Volume Reduces Epithelial and Endothelial Injury in Acid-injured Rat Lungs. American Journal of Respiratory and Critical Care Medicine. 165(2). 242–249. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact